S80260 |
Satraplatin |
源葉(MedMol) | 98% |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.999 ml | 9.994 ml | 19.989 ml |
5 mM | 0.4 ml | 1.999 ml | 3.998 ml |
10 mM | 0.2 ml | 0.999 ml | 1.999 ml |
50 mM | 0.04 ml | 0.2 ml | 0.4 ml |
- 提示:詳情請(qǐng)下載說明書。
- 產(chǎn)品描述: Satraplatin is an orally available antineoplastic platinum(IV) complex.Satraplatin has a favorable toxicity profile and appears to have clinical activity against a variety of malignancies.
- 靶點(diǎn): DNA Alkylation;DNA Alkylator/Crosslinker;DNAAlkylator/Crosslinker;DNAAlkylation
- 細(xì)胞實(shí)驗(yàn): CDDP-resistant (KB-R) cells and parental cells (KB) pair were used. Viability was assessed using the MTT and clonogenic assay. Real-time polymerase chain reaction (PCR), glutathione (GSH) assay, and flow cytometric analysis were used for further assessment
- 參考文獻(xiàn):
1. Yamano Y , Shiiba M , Negoro K , et al. Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cells[J]. Head & Neck, 2010, 33(3):309-317. 2. Bhargava A , Vaishampayan U N . Satraplatin: leading the new generation of oral platinum agents[J]. Expert Opinion on Investigational Drugs, 2009, 18(11):1787-1797.
- 溶解性: Soluble in DMSO
- 保存條件: -20°C
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 1.999 ml 9.994 ml 19.989 ml 5 mM 0.4 ml 1.999 ml 3.998 ml 10 mM 0.2 ml 0.999 ml 1.999 ml 50 mM 0.04 ml 0.2 ml 0.4 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):
本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)